1. Home
  2. CSQR vs ARQT Comparison

CSQR vs ARQT Comparison

Compare CSQR & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Csquare Inc. Common Stock

CSQR

Csquare Inc. Common Stock

SELL

Current Price

$17.28

Market Cap

2.9B

Sector

Technology

ML Signal

SELL

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

SELL

Current Price

$26.09

Market Cap

3.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CSQR
ARQT
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.2B
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
CSQR
ARQT
Price
$17.28
$26.09
Analyst Decision
Buy
Buy
Analyst Count
10
7
Target Price
$28.40
★ $37.00
AVG Volume (30 Days)
1.7M
★ 3.0M
Earning Date
11-20-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 88.79
EPS
N/A
★ 0.03
Revenue
N/A
★ $376,072,000.00
Revenue This Year
$16.12
$42.98
Revenue Next Year
$15.55
$27.75
P/E Ratio
★ N/A
$874.00
Revenue Growth
N/A
★ 91.34
52 Week Low
$15.58
$19.30
52 Week High
$23.50
$31.77

Technical Indicators

Market Signals
Indicator
CSQR
ARQT
Relative Strength Index (RSI) 43.80 55.98
Support Level $16.62 $24.91
Resistance Level $18.67 $28.05
Average True Range (ATR) 0.84 1.13
MACD 0.13 0.05
Stochastic Oscillator 46.53 74.44

Price Performance

Historical Comparison
CSQR
ARQT

About CSQR Csquare Inc. Common Stock

Csquare Inc is an enterprise digital infrastructure platform, owning and operating a geographically diverse portfolio of carrier-neutral data centers located across the United States, Canada and the United Kingdom. The company provides carrier-neutral colocation and interconnection services that provide infrastructure, including space, power, cooling systems, physical security, and interconnection capabilities, enabling customers to deploy and operate IT and network infrastructure. Its facilities support enterprise, network, cloud, and technology customers in the deployment and operation of IT and network infrastructure. The company generates the majority of its revenue from enterprise colocation services, which include fees for the licensing of cabinet space and power.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: